Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 19.212\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CC(=O)c1ccccc1NCC(=O)Nc1ccc(C)cc1
b. CCCCN1C(=O)C(=O)N(CC(=O)NC2CCCc3ccccc32)C1=O
c. CCn1c(CNC(=O)c2ccccc2Cl)cc2ccccc21
d. Cc1c(OCC(=O)NCCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCC3
Answer: d. Cc1c(OCC(=O)NCCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(OCC(=O)NCCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCC3
Cc1c(OCC(=O)NCCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCC3
2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]-N-(3-morpholin-4-ylpropyl)acetamide